— Know what they know.
Not Investment Advice
Also trades as: ZYXIQ (OTC) · $vol 0M

ZYXI NASDAQ

Zynex, Inc.
1W: +100.0% 1M: +0.1% 3M: -85.6% YTD: -25.9% 1Y: -98.9% 3Y: -99.4% 5Y: -99.5%
$0.12
Last traded 2026-02-23 — delisted
NASDAQ · Healthcare · Medical - Distribution · $3.8M mcap · 16M float · 37.86% daily turnover · Short 43% of daily vol

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$192M +4.4% ▲
5Y CAGR: +33.4%
Gross Profit
$153M +4.8% ▲
5Y CAGR: +33.1%
Operating Income
$6M -44.4% ▼
5Y CAGR: -11.6%
Net Income
$3M -69.2% ▼
5Y CAGR: -20.6%
EPS (Diluted)
$0.09 -66.7% ▼
5Y CAGR: -18.5%
EBITDA
$11M -39.7% ▼
5Y CAGR: -1.8%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$80M$130M$158M$184M$192M
YoY Growth+76.2%+62.6%+21.4%+16.5%+4.4%
Cost of Revenue$17M$27M$32M$38M$39M
Gross Profit$63M$103M$126M$146M$153M
Gross Margin78.3%79.3%79.8%79.2%79.5%
R&D Expenses$0$3M$0$0$0
SG&A Expenses$52M$77M$103M$135M$147M
Operating Expenses$52M$81M$103M$135M$147M
Operating Income$10M$22M$23M$11M$6M
Operating Margin12.8%17.2%14.5%5.8%3.1%
Interest Expense$19K$95K$440K$1M$2M
Income Before Tax$10M$22M$22M$13M$4M
Tax Expense$1M$5M$5M$3M$633K
Net Income$9M$17M$17M$10M$3M
Net Margin11.3%13.1%10.8%5.3%1.6%
EPS (Diluted)$0.24$0.40$0.44$0.27$0.09
EBITDA$12M$25M$26M$18M$11M
Shares Outstanding38M43M39M36M32M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms